These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35997006)

  • 1. Validating the Assumptions of Population Adjustment: Application of Multilevel Network Meta-regression to a Network of Treatments for Plaque Psoriasis.
    Phillippo DM; Dias S; Ades AE; Belger M; Brnabic A; Saure D; Schymura Y; Welton NJ
    Med Decis Making; 2023 Jan; 43(1):53-67. PubMed ID: 35997006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel network meta-regression for population-adjusted treatment comparisons.
    Phillippo DM; Dias S; Ades AE; Belger M; Brnabic A; Schacht A; Saure D; Kadziola Z; Welton NJ
    J R Stat Soc Ser A Stat Soc; 2020 Jun; 183(3):1189-1210. PubMed ID: 32684669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When does the use of individual patient data in network meta-analysis make a difference? A simulation study.
    Kanters S; Karim ME; Thorlund K; Anis A; Bansback N
    BMC Med Res Methodol; 2021 Jan; 21(1):21. PubMed ID: 33435879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study.
    Phillippo DM; Dias S; Ades AE; Welton NJ
    Stat Med; 2020 Dec; 39(30):4885-4911. PubMed ID: 33015906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART.
    Kanters S; Karim ME; Thorlund K; Anis AH; Zoratti M; Bansback N
    BMC Med Res Methodol; 2021 Mar; 21(1):60. PubMed ID: 33784981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses.
    Harari O; Soltanifar M; Cappelleri JC; Verhoek A; Ouwens M; Daly C; Heeg B
    Res Synth Methods; 2023 Mar; 14(2):211-233. PubMed ID: 36283960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using individual participant data to improve network meta-analysis projects.
    Riley RD; Dias S; Donegan S; Tierney JF; Stewart LA; Efthimiou O; Phillippo DM
    BMJ Evid Based Med; 2023 Jun; 28(3):197-203. PubMed ID: 35948411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Meta-analysis on Disconnected Evidence Networks When Only Aggregate Data Are Available: Modified Methods to Include Disconnected Trials and Single-Arm Studies while Minimizing Bias.
    Thom H; Leahy J; Jansen JP
    Med Decis Making; 2022 Oct; 42(7):906-922. PubMed ID: 35531938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the impact of a matching-adjusted indirect comparison in a Bayesian network meta-analysis.
    Leahy J; Walsh C
    Res Synth Methods; 2019 Dec; 10(4):546-568. PubMed ID: 31368653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian network meta-analysis methods for combining individual participant data and aggregate data from single arm trials and randomised controlled trials.
    Singh J; Gsteiger S; Wheaton L; Riley RD; Abrams KR; Gillies CL; Bujkiewicz S
    BMC Med Res Methodol; 2022 Jul; 22(1):186. PubMed ID: 35818035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the consistency assumptions underlying network meta-regression using aggregate data.
    Donegan S; Dias S; Welton NJ
    Res Synth Methods; 2019 Jun; 10(2):207-224. PubMed ID: 30367548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesizing cross-design evidence and cross-format data using network meta-regression.
    Hamza T; Chalkou K; Pellegrini F; Kuhle J; Benkert P; Lorscheider J; Zecca C; Iglesias-Urrutia CP; Manca A; Furukawa TA; Cipriani A; Salanti G
    Res Synth Methods; 2023 Mar; 14(2):283-300. PubMed ID: 36625736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjustment for reporting bias in network meta-analysis of antidepressant trials.
    Trinquart L; Chatellier G; Ravaud P
    BMC Med Res Methodol; 2012 Sep; 12():150. PubMed ID: 23016799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma.
    Maciel D; Jansen JP; Klijn SL; Towle K; Dhanda D; Malcolm B; Cope S
    Value Health; 2024 Apr; ():. PubMed ID: 38679290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods and characteristics of published network meta-analyses using individual patient data: protocol for a scoping review.
    Veroniki AA; Soobiah C; Tricco AC; Elliott MJ; Straus SE
    BMJ Open; 2015 Apr; 5(4):e007103. PubMed ID: 25926144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joining the Dots: Linking Disconnected Networks of Evidence Using Dose-Response Model-Based Network Meta-Analysis.
    Pedder H; Dias S; Bennetts M; Boucher M; Welton NJ
    Med Decis Making; 2021 Feb; 41(2):194-208. PubMed ID: 33448252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penalized Poisson model for network meta-analysis of individual patient time-to-event data.
    Ollier E; Blanchard P; Le Teuff G; Michiels S
    Stat Med; 2022 Jan; 41(2):340-355. PubMed ID: 34710951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of adaptive platform trials using a network approach.
    Marschner IC; Schou IM
    Clin Trials; 2022 Oct; 19(5):479-489. PubMed ID: 35993542
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.